Fighting Life-Threatening Sepsis with Nanoparticles | Breakthroughs Can't Wait
Ryan Pearson, PhD, associate professor of pharmaceutical sciences and director of the Bio- and Nano-Technology Center at the University of Maryland School of Pharmacy has been awarded a $3.4 million grant from the National Institutes of Health to move forward with a unique approach to defeating sepsis using nanoparticles. His approach is different because the custom-designed nanoparticles are not used to transport other drugs, but are themselves the treatment.
More from Youtube
- 0:49Meet Dr. Ryan Pearson | Fighting Sepsis with NanoparticlesDr. Ryan Pearson from the University of Maryland School of Pharmacy is using nanoparticles to fight sepsis, one of the deadliest medical emergencies. #BreakthroughsCantWaitUMB #SepsisResearch #Nanomedicine #UMBresearch
- 0:40UMB Founders Week Staff Lunch 2025UMB President Bruce Jarrell, UMB deans, administrators, and vice presidents served lunch in appreciation of our dedicated staff during this annual Founders Week tradition.
- 0:42UMB Student Cookout | Founders Week 2025University of Maryland, Baltimore had the opportunity to get a free lunch from President Bruce E. Jarrell, MD, FACS, deans and vice presidents in this annual Founders Week tradition.
- 2:55Fighting Life-Threatening Sepsis with Nanoparticles | Breakthroughs Can't WaitRyan Pearson, PhD, associate professor of pharmaceutical sciences and director of the Bio- and Nano-Technology Center at the University of Maryland School of Pharmacy has been awarded a $3.4 million grant from the National Institutes of Health to move forward with a unique approach to defeating sepsis using nanoparticles. His approach is different because the custom-designed nanoparticles are not used to transport other drugs, but are themselves the treatment.
- 2:10Can a proven cancer drug be reimagined to fight brain tumors in kids? | Breakthroughs Can't WaitAs an ACS-IMPACT Research Scholar at the University of Maryland, Baltimore, Gabrielle Olibris spent her summer in the lab of Aditi Banerjee, PhD, targeting medulloblastoma, a pediatric brain cancer, with a novel therapeutic compound called BNPP-433.3 Beta.BNPP-433.3 Beta shows strong potential, she said, explaining, “This is already patented, so it’s a drug that’s already being used to treat prostate cancer.”By exploring a new use for an existing cancer drug, Olibris hopes to help advance research that could lead to safer, more effective treatments for children.#breakthroughscantwaitumb #cancerresearch
- 2:28Student of the Year Danielle D. Basdekis | Founders Week 2025With a passion for social justice and public interest law, Danielle Basdekis arrived at the University of Maryland Francis King Carey School of Law in 2023 to pursue a Juris Doctor degree and hit the ground running. In two years, she has distinguished herself as a student, scholar, and leader, with her contributions significantly enriching the law school and advancing the mission of the University of Maryland, Baltimore (UMB).The third-year student has made her mark on the Francis King Carey School of Law through her academic pursuits and leadership roles. Basdekis, who will be a clerk for Justice Angela Eaves on the Supreme Court of Maryland after graduating next spring, said she was “overwhelmed” by the Student of the Year honor.Read more: https://elm.umaryland.edu/elm-stories/2025/Founders-Week-2025-Student-of-the-Year-Danielle-D-Basdekis.php
